MRI Contrast Problems lead to FDA warning
Today the FDA requested that a black box warning be added to MRI contrast agents which are gadolinium-based. For those with kidney problems, an MRA or MRI with contrast could lead to a debilitating and potentially fatal condition known as nephrogenic systemic fibrosis (NSF). Problems with the MRI contrast agents have caused life-changing injuries for hundreds of people, and the nephrogenic systemic fibrosis lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential lawsuits nationwide against the manufacturers of these contrast agents.
>>INFORMATION: MRI Contrast Problems
The gadolinium contrast warning will state that individuals with kidney insufficiency are at risk of developing nephrogenic systemic fibrosis (NSF) if they are given one of five MRI contrast dyes. In addition, those who receive a contrast dye just before or after a liver transplant, or if they have chronic liver disease, could develop NSF since they have an increased risk of developing kidney problems.
Nephrogenic systemic fibrosis is associated with the development of thick and hard skin which covers the joints leading to severe limitations on movement. In many cases those diagnosed require a wheelchair within weeks after the onset of symptoms. The condition has also been associated with thickening or scarring of the tissues of internal organs. For some, the condition can lead to death.
>>INFORMATION: Nephrogenic systemic fibrosis symptoms
The FDA has requested that all five gadolinium contrast agents add the warning to their label. However, the majority of problems have been associated with Omniscan MRI contrast, which is manufactured by GE. The contrast dyes are approved for use with MRI, so that doctors can better visualize internal structures. However, in many cases they are given off-label as a MRA contrast dye to aid in detection of heart disorders, strokes and vascular diseases. When given during an MRA, the gadolinium contrast is given at much higher doses.
NEPHROGENIC SYSTEMIC FIBROSIS LAWYERS
If you, a friend or family member experienced MRI contrast problems you may have a claim. The attorneys at Saiontz, Kirk & Miles, P.A. are reviewing potential nephrogenic systemic fibrosis lawsuits for individuals with kidney problems or liver problems who experienced thickening of the skin or limited mobility after receiving an MRA or MRI with contrast.
